NVAX
Price
$10.11
Change
+$0.11 (+1.10%)
Updated
Sep 18 closing price
Capitalization
1.67B
46 days until earnings call
Intraday BUY SELL Signals
TINY
Price
$74.07
Change
+$1.51 (+2.08%)
Updated
Sep 18 closing price
Net Assets
12.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

NVAX vs TINY

NVAX vs TINY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NVAX vs. TINY commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and TINY is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXTINY
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
COMPARISON
Comparison
Sep 21, 2026
Stock price -- (NVAX: $10.11)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 1 FA rating(s) are green while .

  • NVAX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 5 TA indicator(s) are bullish.

  • NVAX’s TA Score: 5 bullish, 6 bearish.

Price Growth

NVAX (@Biotechnology) experienced а +7.32% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.53%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +7.13%.

Reported Earning Dates

NVAX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NVAX
Daily Signal:
Gain/Loss:
TINY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NVDY12.530.15
+1.21%
YieldMax NVDA Option Income Strategy ETF (NVDY)
MTYY17.680.01
+0.08%
GraniteShares YieldBOOST MSTR ETF (MTYY)
QQUP60.17N/A
N/A
ProShares Ultra Top QQQ
AJUL30.19-0.03
-0.09%
Innovator 2 Yr to July 2028 (AJUL)
AFB10.10-0.17
-1.66%
Alliance National Municipal Income Fund

TINY and

Correlation & Price change

A.I.dvisor tells us that TINY and TKNO have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TINY and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TINY
1D Price
Change %
TINY100%
+2.09%
TKNO - TINY
8%
Poorly correlated
+4.56%
NVAX - TINY
6%
Poorly correlated
+1.10%
NVDA - TINY
5%
Poorly correlated
+1.34%
MRVI - TINY
4%
Poorly correlated
-4.13%
KLAC - TINY
2%
Poorly correlated
+4.74%
More